Shilpa N Bhupathiraju1, Francine Grodstein1, Meir J Stampfer1, Walter C Willett1, Frank B Hu1, JoAnn E Manson1. 1. At the time of study, Shilpa N. Bhupathiraju, Meir J. Stampfer, Walter C. Willett, and Frank B. Hu were with the Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA. Francine Grodstein and JoAnn E. Manson were with the Department of Epidemiology, Harvard T. H. Chan School of Public Health.
Abstract
OBJECTIVES: To review the contribution of the Nurses' Health Study (NHS) to our understanding of the complex relationship between exogenous hormones and health outcomes in women. METHODS: We performed a narrative review of the publications of the NHS and NHS II from 1976 to 2016. RESULTS: Oral contraceptive and postmenopausal hormone use were studied in relation to major health outcomes, including cardiovascular disease and cancer. Current or recent oral contraceptive use is associated with a higher risk of cardiovascular disease (mainly among smokers), melanoma, and breast cancer, and a lower risk of colorectal and ovarian cancer. Although hormone therapy is not indicated primarily for chronic disease prevention, findings from the NHS and a recent analysis of the Women's Health Initiative indicate that younger women who are closer to menopause onset have a more favorable risk-benefit profile than do older women from use of hormone therapy for relief of vasomotor symptoms. CONCLUSIONS: With updated information on hormone use, lifestyle factors, and other variables, the NHS and NHS II continue to contribute to our understanding of the complex relationship between exogenous hormones and health outcomes in women.
OBJECTIVES: To review the contribution of the Nurses' Health Study (NHS) to our understanding of the complex relationship between exogenous hormones and health outcomes in women. METHODS: We performed a narrative review of the publications of the NHS and NHS II from 1976 to 2016. RESULTS: Oral contraceptive and postmenopausal hormone use were studied in relation to major health outcomes, including cardiovascular disease and cancer. Current or recent oral contraceptive use is associated with a higher risk of cardiovascular disease (mainly among smokers), melanoma, and breast cancer, and a lower risk of colorectal and ovarian cancer. Although hormone therapy is not indicated primarily for chronic disease prevention, findings from the NHS and a recent analysis of the Women's Health Initiative indicate that younger women who are closer to menopause onset have a more favorable risk-benefit profile than do older women from use of hormone therapy for relief of vasomotor symptoms. CONCLUSIONS: With updated information on hormone use, lifestyle factors, and other variables, the NHS and NHS II continue to contribute to our understanding of the complex relationship between exogenous hormones and health outcomes in women.
Authors: D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings Journal: Ann Intern Med Date: 1992-12-15 Impact factor: 25.391
Authors: Brittany M Charlton; Kana Wu; Xuehong Zhang; Edward L Giovannucci; Charles S Fuchs; Stacey A Missmer; Bernard Rosner; Susan E Hankinson; Walter C Willett; Karin B Michels Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-10 Impact factor: 4.254
Authors: R J Lipnick; J E Buring; C H Hennekens; B Rosner; W Willett; C Bain; M J Stampfer; G A Colditz; R Peto; F E Speizer Journal: JAMA Date: 1986-01-03 Impact factor: 56.272
Authors: L Chasan-Taber; W C Willett; J E Manson; D Spiegelman; D J Hunter; G Curhan; G A Colditz; M J Stampfer Journal: Circulation Date: 1996-08-01 Impact factor: 29.690
Authors: M E Martínez; F Grodstein; E Giovannucci; G A Colditz; F E Speizer; C Hennekens; B Rosner; W C Willett; M J Stampfer Journal: Cancer Epidemiol Biomarkers Prev Date: 1997-01 Impact factor: 4.254
Authors: Jennifer H Lin; Teppei Morikawa; Andrew T Chan; Aya Kuchiba; Kaori Shima; Katsuhiko Nosho; Gregory Kirkner; Shumin M Zhang; Joann E Manson; Edward Giovannucci; Charles S Fuchs; Shuji Ogino Journal: Cancer Res Date: 2012-04-17 Impact factor: 12.701
Authors: J E Manson; E B Rimm; G A Colditz; W C Willett; D M Nathan; R A Arky; B Rosner; C H Hennekens; F E Speizer; M J Stampfer Journal: Ann Epidemiol Date: 1992-09 Impact factor: 3.797
Authors: Somdat Mahabir; Walter C Willett; Christine M Friedenreich; Gabriel Y Lai; Carol J Boushey; Charles E Matthews; Rashmi Sinha; Graham A Colditz; Joseph A Rothwell; Jill Reedy; Alpa V Patel; Michael F Leitzmann; Gary E Fraser; Sharon Ross; Stephen D Hursting; Christian C Abnet; Lawrence H Kushi; Philip R Taylor; Ross L Prentice Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-12-18 Impact factor: 4.254
Authors: Carolyn J Crandall; Kathleen M Hovey; Christopher A Andrews; Rowan T Chlebowski; Marcia L Stefanick; Dorothy S Lane; Jan Shifren; Chu Chen; Andrew M Kaunitz; Jane A Cauley; JoAnn E Manson Journal: Menopause Date: 2018-01 Impact factor: 2.953
Authors: David J Cote; John L Kilgallon; Noah L A Nawabi; Hassan Y Dawood; Timothy R Smith; Ursula B Kaiser; Edward R Laws; JoAnn E Manson; Meir J Stampfer Journal: J Clin Endocrinol Metab Date: 2022-03-24 Impact factor: 5.958
Authors: Rebecca B Lawn; Kristen M Nishimi; Yongjoo Kim; Sun Jae Jung; Andrea L Roberts; Jennifer A Sumner; Rebecca C Thurston; Lori B Chibnik; Eric B Rimm; Andrew D Ratanatharathorn; Shaili C Jha; Karestan C Koenen; Shelley S Tworoger; Laura D Kubzansky Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-12-21 Impact factor: 4.254